CRLX101
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for CRLX101, covering 2017-05-24 to 2026-06-18. Get the full timeline:
Most recent: Clinical Trial Results: A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1, Phase 2]